Scientific publications

Blood Cancer Journal, 2026

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

Firestone R., Simhal A., Akhlaghi T. et al.

Atherosclerosis, 2026

Inflammation may explain part of atherosclerotic cardiovascular disease risk conferred by elevated remnant lipoproteins: a cohort and Mendelian randomization study

Wadström B., Wulff A., Pedersen K. et al.

JHEP Reports, 2026

Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B

Holmberg M., Niehrs A., Dalgard O. et al.

eBioMedicine, 2026

A randomized, observer-blind, phase 1 study of immune responses to three human adenovirus type 26 vector–based vaccines

Hertoghs N., Serroyen J., Tolboom J. et al.

Archives of Medical Science, 2026

Deciphering the Interplay Between Inflammatory Factors and Brain Structural Features in Epilepsy

Fang S., Dong X., Li X. et al.

Neurobiology of Disease, 2026

Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity

Jin H., Meng L., Yulug B. et al.

Neurobiology of Disease, 2026

A NETs-centric multi-omics framework prioritizes PGLYRP1 and MMP9 as subtype-associated thromboinflammatory biomarker candidates and putative therapeutic hypotheses in ischemic stroke

Tan H., Gong H., Li H. et al.

Lung Cancer, 2026

A dynamic proteomic signature for the prediction of lung Cancer: a longitudinal analysis in the UK Biobank cohort

Liang J., Feng Y., Gui D. et al.

Journal of Infection, 2026

Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoir

Suanzes P., Grau-Expósito J., Navarro J. et al.

Nature Biotechnology, 2026

mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression

Marks A., Siu S., Bianchini F. et al.

Nature Genetics, 2026

Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations

Koller D., He J., Løkhammer S. et al.

Nature Medicine, 2026

Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial

Li H., Xu Y., Chen Y. et al.

BMC Medicine, 2026

Adherence to the EAT-Lancet Diet, plasma proteomics, and risk of venous thromboembolism: a large-scale prospective cohort study

He Q., Sun M., Wang Y. et al.

Urogenital Tract Infection, 2026

Identification of Plasma Biomarker Signatures for Acute and Chronic Cystitis Using Olink Explore Proteomics in UK Biobank

Kang C., Kim S.

BioData Mining, 2026

Divide-and-conquer analysis reveals hidden immune cell influencers across the placenta in preeclampsia

Paik H., Ko T., Park M. et al.

Leukemia & Lymphoma, 2026

Targeting the IL-8 axis in high-risk myelodysplastic syndromes: a clinical experience with antibody blockade combined with decitabine/cedazuridine

Mina A., Calvo K., McKinnon K. et al.

International Journal of Molecular Sciences, 2026

UK Biobank-Based Genetic and Proteomic Network Insights into Metabolic Dysfunction-Associated Steatotic Liver Disease Pathogenesis

Kang S., Kim S., Ban J. et al.

International Journal of Molecular Sciences, 2026

Plasma Proteomic Signatures of Glucose Metabolism Disturbances and Early Diabetes

Zieleniewska N., Jamiołkowski J., Malarstig A. et al.

Clinical Cardiology, 2026

Plasma EDA2R and Risk of Cardiovascular Diseases and All‐Cause Mortality: Analysis of the UK Biobank Cohort

Ruan Z., Tu J., Xu H. et al.

Nature Medicine, 2026

AI framework for multidisease detection via retinal imaging

Zhang X., Li Q., Liang Y. et al.